NCT03914820 2023-10-27
CHECK
Mario Negri Institute for Pharmacological Research
Phase NA Unknown
Clinical Trials
12 trialsNCT02614534 2023-09-28
HIPECT4
Maimónides Biomedical Research Institute of Córdoba
Phase 3 Unknown
NCT02948543 2023-06-18
BCG+MM
University of Sydney
Phase 3 Unknown
NCT03073694 2023-06-09
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
University of Kansas Medical Center
Phase 2 Unknown
NCT02526953 2021-02-09
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT04115410 2020-05-28
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Unknown
NCT02070120 2020-03-19
CALIBER
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT02369939 2017-08-11
HYCAN
University of Erlangen-Nürnberg Medical School
Phase 3 Unknown
NCT02301091 2016-04-14
CORTT
Sun Yat-sen University
Phase 3 Unknown
NCT02638857 2016-01-01
Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma
Second Military Medical University
Phase 1/2 Unknown
NCT01511146 2012-01-19
Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor
Copenhagen University Hospital at Herlev
Phase 2 Unknown
NCT01196455 2010-09-08
Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
Croatian Cooperative Group for Clinical Research in Oncology
Phase 2 Unknown